Streetbeat News

Earnings

COEP

Coeptis Therapeutics has completed its Phase 1 trial for COVID-19-related infections and is advancing its cell therapy platforms. The company raised $5.6 million in capital and is appealing a Nasdaq delisting decision. Strategic partnerships and new developments in cell therapy are key growth drivers.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:19 pm

YEXT

Yext shares rose following a strong Q2 earnings report and positive FY25 revenue guidance. Needham upgraded the stock to Buy with an $8 price target.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:16 pm

VRNT

Verint Systems shares declined following the release of disappointing Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:15 pm

TAOP

Taoping (NASDAQ:TAOP) reported a significant improvement in its financial performance for the first half of the year, with earnings per share (EPS) rising to $0.13 from a loss of $(1.10) the previous year, and sales increasing by 28.42% to $18.08 million.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:15 pm

BASE

Couchbase shares declined after the company reported disappointing Q2 EPS results and announced it cannot provide GAAP targets for Q3 and FY25. Additionally, Piper Sandler and Baird lowered their price targets for the stock.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:13 pm

CXM

Sprinklr (NYSE:CXM) reported mixed Q2 results, missing EPS estimates but beating revenue expectations. The company lowered its FY25 EPS guidance, leading analysts to cut price targets. Sprinklr's stock fell 1.9% following the announcement.

Portfolio Pulse from Avi Kapoor

September 05, 2024 | 12:09 pm

AI

C3.ai reported strong Q1 earnings with revenue of $87.2 million, beating estimates. Despite this, analysts lowered their price targets, leading to a 1.9% drop in share price.

Portfolio Pulse from Avi Kapoor

September 05, 2024 | 12:01 pm

WLY

Wiley has reaffirmed its financial outlook for FY25, projecting adjusted EPS between $3.25 and $3.60, and adjusted revenue between $1.65 billion and $1.69 billion. These projections align closely with market estimates, indicating stability in the company's financial performance. Wiley also remains on track to meet its FY26 targets.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 11:57 am

AI

C3 AI shares declined following the release of their Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 11:57 am

HPE

Hewlett Packard Enterprise (HPE) shares are trading lower following the release of their Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 11:55 am